Phenotype of fibrinolytic activity and prophylaxis of hyperfibrinolysis in the course of liver transplantation

E.V. Kraisvetnaya, V.V. Osovskikh, A.E. Bautin, D.A. Granov
Keywords: liver transplantation, hypofibrinolysis, thromboelastometry.
Medicinskij al'manah, 2017, issue 3, pages 150-154.

Нyperfibrinolysis is a common cause of non-surgical blood loss during orthotopic liver transplantation (OLT).
The incidence of hypofibrinolysis and its impact on outcomes for OLT recipients are not known. The aim of
the study was to determine the distribution of the phenotypes of fibrinolytic activity (FA) in patients before
OLT with the rotational thromboelastometry (TEM) and to assess the predictive value of the identified phenotypes.
The study was conducted in 146 patients having undergone OLT. At certain time points of the
operation (5 points) TEM was examined, as well as the screening coagulation profile. The current criteria of
normo-, hyper- and hypophybrinolysis described in the literature were used. Patient’s groups with identified
FA phenotypes were compared for a number of laboratory and clinical variables. At the beginning of the
operation the normal fibrinolysis was detected in 64,6%, hypofibrinolysis – in 33,3%, and hyperfibrinolysis in
2,1% of patients. Although patients with normo- and hypofibrinolysis significantly differed in a number of
laboratory parameters, there were no significant differences in the volume of blood loss, the thrombotic
complication rate and the duration of ICU-stay. The detection of the phenotype of hypophybrinolysis in the
recipient before OLT is apparently not a significant risk factor.

1. Ferro D., Celestini A. Hyperfibrinolysis in liver disease. Clinical Liver Disease.

2009. № 13. P. 21-22.
2. Lisman T., Porte R.J. Rebalanced hemostasis in patients with liver disease:
evidence and clinical consequences. Blood. 2010. Vol. 116 (6). P. 878-880.
3. Hu K.Q., Yu A.S., Tyyagura L. et al. Hyperfibrinolysis activity in hospitalized
cirrhotic patients in a referral liver unit. American Journal Gastroenterology. 2001.
№ 96. P. 1581.
4. Ferro D., Quintarelli C., Saliola M. et al. Prevalence of hyperfibrinolysis in
patients with liver cirrhosis. Fibrinolysis. 1993. № 7. P. 59-62.
5. Munoz S.J., Stravitz R.T., Gabriel D.A. Coagulopathy of Acute Liver Failure. Clin
Liver Dis. 2009. № 13. P. 95-107.
6. Segal H., Cottam S., Potter D. et al. Coagulation and fibrinolysis in primary
biliary cirrhosis compared with other liver disease and during orthotopic liver
transplantation. Hepatology. 1997. № 25. P. 683-688.
7. Starzl T.E., Marchioro T.L., Von Kaulla K.N. et al. Homotransplantation of he
liver in humans. Surg Gynecol Obstet. 1963. № 117. P. 659-676.
8. De Boer M.T., Molenaar I.Q., Hendriks H.G. et al. Minimizing blood loss in liver
transplantation: progress through research and evolution of techniques. Dig Surg.
2005. № 22. P. 265-275.
9. Krzanicki D., Sugavanam A., Mallett S. Intraoperative hypercoagulability
during liver transplantation as demonstrated by thromboelastography. Liver
transplantation. 2013. № 19. P. 852-861.
10. Hartmann M., Szalai C., Saner F.H. Hemostasis in liver transplantation:
Pathophysiology, monitoring, and treatment. World Journal of Gastroenterology.
2016. Jan. 28. № 22 (4). P. 1544.
11. Moore E.E., Moore H.B., Gonzalez E. et al. Rationale for the selective
administration of tranexamic acid to inhibit fibrinolysis in the severely injured
patient. Transfusion. 2016. № 56. P. 110-111.
12. Moore H.B., Moore E.E., Gonzalez E. et al. Hyperfibrinolysis, physiologic
fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis
and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014. № 77.
P. 386-392.
13. Wang S.C., Shieh J.F., Chang K.Y. et al. Thromboelastography-guided
transfusion decreases intraoperative blood transfusion during orthotopic liver
transplantation: randomized clinical trial. Transplant Proc. 2010. № 42.
P. 2590-2593.
14. Gorlinger K. Coagulation management during liver transplantation.
Haemostaseology. 2006. № 26. Vol. 68. P. 64-76.
15. Porte R.J., Bontempo F.A., Knot E.A. et al. Systemic effects of tissue
plasminogen activator-associated fibrinolysis and its relation to thrombin generation
in orthotopic liver transplantation. Transplantation. 1989. № 66. P. 978-984.
16. Warnaar N., Molenaar Q., Colquhoun S.D. et al. Intraoperative pulmonary
embolism and intracardiac thrombosis complicating liver transplantation: a
systematic review. Journal of thrombosis and Haemostasis. № 6. P. 297-302.
17. Adamzic M., Eggman M., Frey U.H., Gorlinger K. et al. Comparison of
thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as
diagnostic tests for severe sepsis in critically ill adults. Critical Care. 2010. № 14 (5). P. 178.

E.V. Kraisvetnaya, V.V. Osovskikh, A.E. Bautin, D.A. Granov Phenotype of fibrinolytic activity and prophylaxis of hyperfibrinolysis in the course of liver transplantation. Medicinskij al'manah 2017; (3): 150–154, http://dx.doi.org/10.21145/2499-9954-2017-3-150-154